官方服务：
资源简介：
Dermatologic Manifestations of Semaglutide Supplementary Table
应用场景：
创建时间：
2024-03-04
相关数据集
泰州市药品不良反应监测分析数据集
泰州市药品不良反应监测分析数据集由泰州市药品检验院（泰州市药品和医疗器械不良反应监测中心）收集、整理和分析，旨在全面反映泰州市药品不良反应情况的数据集合。该数据集包含了药品不良反应的各种信息，如不良反应类型、发生频率、涉及药品、患者信息等，为药品安全监管、研发、监测和临床用药提供了重要依据。
江苏数据知识产权登记系统2025-03-20 更新520
Side effects reported by female participants during the follow-up period by study arm.
Side effects reported by female participants during the follow-up period by study arm.
Figshare2022-02-17 更新60
Adverse events by age and treatment group within the first week of follow up.
Adverse events by age and treatment group within the first week of follow up.
NIAID Data Ecosystem50
Effectiveness and Safety of Oral Tofacitinib in Patients with Recalcitrant Frontal Fibrosing Alopecia: A Pilot Study
Mendeley Supplementary Figure 1. Clinical photographs of a patient with refractory FFA, showing the eyebrows before (A) and after (B) 12 weeks of oral tofacitinib therapy. Notable improvements include
DataCite Commons2025-04-14 更新240
Metoprolol adverse events and literature analyses: case/non-case analyses using the FDA Adverse Event Reporting System (FAERS)
In recent years, β-blockers such as metoprolol have been upgraded to first-line antihypertensive drugs. However, metoprolol demonstrates poor prognosis effects on diseases such as stroke. Further clin
Figshare2024-12-24 更新50
